Following news of hardships at Proteus Digital Health, CEO Andrew Thompson has told STAT News that the company is winding down its high-profile $88 million deal with Otsuka Pharmaceutical, and will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback